Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY.
Am J Transplant. 2015 Apr;15(4):914-22. doi: 10.1111/ajt.13173. Epub 2015 Feb 3.
Live donor kidney transplantation is the best treatment option for most patients with late-stage chronic kidney disease; however, the rate of living kidney donation has declined in the United States. A consensus conference was held June 5-6, 2014 to identify best practices and knowledge gaps pertaining to live donor kidney transplantation and living kidney donation. Transplant professionals, patients, and other key stakeholders discussed processes for educating transplant candidates and potential living donors about living kidney donation; efficiencies in the living donor evaluation process; disparities in living donation; and financial and systemic barriers to living donation. We summarize the consensus recommendations for best practices in these educational and clinical domains, future research priorities, and possible public policy initiatives to remove barriers to living kidney donation.
活体供肾移植是大多数晚期慢性肾脏病患者的最佳治疗选择;然而,活体供肾捐献在美国的比例却有所下降。为了确定与活体供肾移植和活体供肾捐献相关的最佳实践和知识空白,2014 年 6 月 5 日至 6 日召开了一次共识会议。移植专业人员、患者和其他主要利益攸关方讨论了教育移植候选人及潜在活体供者有关活体供肾捐献的流程;活体供者评估过程中的效率;活体捐献的差异;以及活体捐献的经济和体制障碍。我们总结了这些教育和临床领域最佳实践的共识建议、未来的研究重点以及可能的公共政策举措,以消除活体肾捐献的障碍。